Single Session vs Multiple-Session Panretinal Photocoagulation With Navigated Laser in Proliferative Diabetic Retinopathy - The SMART-PRP Study
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Proliferative diabetic retinopathy (PDR) is the leading cause for blindness in working-age adults. The current gold standard treatment for PDR is panretinal photocoagulation (PRP). In current clinical practice, both single-session and multiple-session PRP approaches are widely accepted and utilized. The purpose of this study is to compare the safety and effectiveness of single-session and multiple-session PRP.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age \> 18 years.
• Patients with type 1 or type 2 Diabetes Mellitus with newly diagnosed Proliferative Diabetic Retinopathy, PDR.
• Visual acuity ≥ 0.1 Snellen.
• CRT of less than 300 micrometer measured by OCT without cysts in the neuroretina.
• Clear media and adequately dilated pupil for PRP.
Locations
Other Locations
Sweden
Ögonmottagning Mölndal/SU
RECRUITING
Mölndal
Contact Information
Primary
Imadeddin Abu Ishkheidem, M.D.
imadeddin.abu.ishkheidem@vgregion.se
+46738744867
Backup
Sofia Töyrä Silfverswärd, PhD
sofia.toyra.silfversward@vgregion.se
+46761283085
Time Frame
Start Date: 2025-01-01
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 40
Treatments
Active_comparator: Single-session panretinal PRP (SS-PRP)
Administration of all panretinal photocoagulation (PRP) treatment in one comprehensive session, typically delivered in a single clinical visit.
Active_comparator: Multiple-session panretinal PRP (MS-PRP)
Administration of panretinal photocoagulation (PRP) treatment over two separate visits with at least one week apart.
Related Therapeutic Areas
Sponsors
Leads: Vastra Gotaland Region